Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Gentiva Health Services Inc Raises FY 2013 Revenue Guidance; Lowers High End Of Prior FY 2013 EPS Guidance To Range In Line With Analysts' Estimates; Comments On Q4 2013 Restructuring Charge Guidance


Tuesday, 5 Nov 2013 07:01am EST 

Gentiva Health Services Inc announced that for fiscal 2013, it expects net revenues to be in the range of $1.72 billion to $1.74 billion. Additionally, the Company expects adjusted income attributable to Gentiva shareholders to be in the range of $0.90 to $1.00 on a diluted per share basis. The Company expects to take restructuring charges in the fourth quarter of 2013 associated with the acquisition and other initiatives. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.67 billion and EPS of $0.92 for fiscal 2013. 

Company Quote

19.05
-0.1 -0.52%
19 Dec 2014